Protective effects of aerobic swimming training on high-fat diet induced nonalcoholic fatty liver disease: Regulation of lipid metabolism via PANDER-AKT pathway

Biochemical and Biophysical Research Communications

Volumn 458, Issue 4, 2015, Pages 862-868

  Wu, Hao ^a   Jin, Meihua ^a   Han, Donghe ^a   Zhou, Mingsheng ^a   Mei, Xifan ^a   Guan, Youfei ^b,c   Liu, Chang ^a  

^a JINZHOU MEDICAL UNIVERSITY   (China)

^b PEKING UNIVERSITY HEALTH SCIENCE CENTER   (China)

^c Shenzhen University School of Medicine   (China)

Author keywords

Exercise; Fatty acid transport; Fatty acid oxidation; FOXO1; Lipogenesis; PPAR

Indexed keywords

3 KETOACYLCOENZYME A THIOLASE; ACYL COENZYME A DESATURASE 1; ACYL COENZYME A OXIDASE; DEATH RECEPTOR; DIACYLGLYCEROL ACYLTRANSFERASE 2; FAS ANTIGEN; FATTY ACID BINDING PROTEIN; FATTY ACID TRANSPORTER 5; LONG CHAIN FATTY ACID; MESSENGER RNA; PANCREATIC DERIVED FACTOR; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA; PROTEIN; PROTEIN KINASE B; STEAROYL COENZYME A; THROMBOSPONDIN 1; TRANSCRIPTION FACTOR FKHR; UNCLASSIFIED DRUG; CYTOKINE; FORKHEAD TRANSCRIPTION FACTOR; FOXO1 PROTEIN, MOUSE; PANDER PROTEIN, MOUSE;

ADAPTATION; AEROBIC EXERCISE; AEROBIC SWIMMING TRAINING; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DIET SUPPLEMENTATION; DISEASE ASSOCIATION; FATTY ACID OXIDATION; FATTY ACID SYNTHESIS; FATTY ACID TRANSPORT; GENE EXPRESSION; GENETIC ASSOCIATION; LIPID DIET; LIPID METABOLISM; LIPOGENESIS; MALE; MOUSE; NONALCOHOLIC FATTY LIVER; NONHUMAN; OXIDATION KINETICS; PRIORITY JOURNAL; SEDENTARY LIFESTYLE; SWIMMING; ADVERSE EFFECTS; ANIMAL; C57BL MOUSE; LIVER; METABOLISM; NON-ALCOHOLIC FATTY LIVER DISEASE; PATHOLOGY; RANDOMIZATION; SIGNAL TRANSDUCTION;

ANIMALS; CYTOKINES; DIET, HIGH-FAT; FORKHEAD TRANSCRIPTION FACTORS; LIPID METABOLISM; LIPOGENESIS; LIVER; MALE; MICE, INBRED C57BL; NON-ALCOHOLIC FATTY LIVER DISEASE; PROTO-ONCOGENE PROTEINS C-AKT; RANDOM ALLOCATION; SIGNAL TRANSDUCTION; SWIMMING;

EID: 84925538709     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2015.02.046     Document Type: Article

References (36)

1. S.D. Lidofsky Nonalcoholic fatty liver disease: diagnosis and relation to metabolic syndrome and approach to treatment Curr. Diab Rep. 8 2008 25 30
2. P. Angulo GI epidemiology: nonalcoholic fatty liver disease Aliment. Pharmacol. Ther. 25 2007 883 889
3. G. Musso, R. Gambino, and M. Cassader Emerging molecular targets for the treatment of nonalcoholic fatty liver disease Annu Rev. Med. 61 2010 375 392
4. A. Sourianarayanane, M.R. Pagadala, and J.P. Kirwan Management of non-alcoholic fatty liver disease Minerva Gastroenterol. Dietol. 59 2013 69 87
5. N.A. Johnson, S.E. Keating, and J. George Exercise and the liver: implications for therapy in fatty liver disorders Semin. Liver Dis. 32 2012 65 79
6. M.S. Gauthier, K. Couturier, and J.G. Latour et al. Concurrent exercise prevents high-fat-diet-induced macrovesicular hepatic steatosis J. Appl. Physiol. 94 2003 1985 2127 2134
7. T. Ueno, H. Sugawara, and K. Sujaku et al. Therapeutic effects of restricted diet and exercise in obese patients with fatty liver J. Hepatol. 27 1997 103 107
8. K. Promrat, D.E. Kleiner, and H.M. Niemeier et al. Randomized controlled trial testing the effects of weight loss on nonalcoholic steatohepatitis Hepatology 51 2010 121 129
9. A. St George, A. Bauman, and A. Johnston et al. Independent effects of physical activity in patients with nonalcoholic fatty liver disease Hepatology 50 2009 68 76
10. C. Wang, B.R. Burkhardt, and Y. Guan et al. Role of pancreatic-derived factor in type 2 diabetes: evidence from pancreatic beta cells and liver Nutr. Rev. 70 2012 100 106
11. J. Li, Y. Chi, and C. Wang et al. Pancreatic-derived factor promotes lipogenesis in the mouse liver: role of the Forkhead box 1 signaling pathway Hepatology 53 2011 1906 1916
12. M. American College of Sports American college of sports medicine position stand. Progression models in resistance training for healthy adults Med. Sci. Sports Exerc 41 2009 687 708
13. Y. Zhou, X. Zhang, and L. Chen et al. Expression profiling of hepatic genes associated with lipid metabolism in nephrotic rats Am. J. Physiol. Ren. Physiol. 295 2008 F662 F671
14. A. Chen, Y. Tang, and V. Davis et al. Liver fatty acid binding protein (L-Fabp) modulates murine stellate cell activation and diet-induced nonalcoholic fatty liver disease Hepatology 57 2013 2202 2212
15. D. Greco, A. Kotronen, and J. Westerbacka et al. Gene expression in human NAFLD Am. J. Physiol. Gastrointest. Liver Physiol. 294 2008 G1281 G1287
16. E.P. Newberry, Y. Xie, and S. Kennedy et al. Decreased hepatic triglyceride accumulation and altered fatty acid uptake in mice with deletion of the liver fatty acid-binding protein gene J. Biol. Chem. 278 2003 51664 51672
17. T. Matsuzaka, A. Atsumi, and R. Matsumori et al. Elovl6 promotes nonalcoholic steatohepatitis Hepatology 56 2012 2199 2208
18. Y. Song, S.J. Lee, and S.H. Jang et al. Sasa borealis stem extract attenuates hepatic steatosis in high-fat diet-induced obese rats Nutrients 6 2014 2179 2195
19. T. Hashimoto, T. Fujita, and N. Usuda et al. Peroxisomal and mitochondrial fatty acid beta-oxidation in mice nullizygous for both peroxisome proliferator-activated receptor alpha and peroxisomal fatty acyl-CoA oxidase. Genotype correlation with fatty liver phenotype J. Biol. Chem. 274 1999 19228 19236
20. D.G. Cotter, B. Ercal, and D.A. d'Avignon et al. Impairments of hepatic gluconeogenesis and ketogenesis in PPARalpha-deficient neonatal mice Am. J. Physiol. Endocrinol. Metab. 307 2014 E176 E185
21. P. Lefebvre, G. Chinetti, and J.C. Fruchart et al. Sorting out the roles of PPAR alpha in energy metabolism and vascular homeostasis J. Clin. Invest 116 2006 571 580
22. P. Kulozik, A. Jones, and F. Mattijssen et al. Hepatic deficiency in transcriptional cofactor TBL1 promotes liver steatosis and hypertriglyceridemia Cell. Metab. 13 2011 389 400
23. L.A. Videla, and P. Pettinelli Misregulation of PPAR Functioning and its pathogenic consequences associated with nonalcoholic fatty liver disease in human obesity PPAR Res. 2012 2012 107434
24. C.M. Trent, S. Yu, and Y. Hu et al. Lipoprotein lipase activity is required for cardiac lipid droplet production J. Lipid Res. 55 2014 645 658
25. M. Vida, A. Serrano, and M. Romero-Cuevas et al. IL-6 cooperates with peroxisome proliferator-activated receptor-alpha-ligands to induce liver fatty acid binding protein (LFABP) up-regulation Liver Int. 33 2013 1019 1028
26. S. Arnauld, M. Fidaleo, and M.C. Clemencet et al. Modulation of the hepatic fatty acid pool in peroxisomal 3-ketoacyl-CoA thiolase B-null mice exposed to the selective PPARalpha agonist Wy14,643 Biochimie 91 2009 1376 1386
27. M. Gao, L. Bu, and Y. Ma et al. Concurrent activation of liver X receptor and peroxisome proliferator-activated receptor alpha exacerbates hepatic steatosis in high fat diet-induced obese mice PLoS One 8 2013 e65641
28. T. Hashimoto, T. Fujita, and N. Usuda et al. Peroxisomal and mitochondrial fatty acid -Oxidation in mice nullizygous for both peroxisome proliferator-activated receptor and peroxisomal fatty Acyl-CoA Oxidase: GENOTYPE CORRELATION with fatty liver PHENOTYPE J. Biological Chem. 274 1999 19228 19236
29. W.H. Hsu, T.H. Chen, and B.H. Lee et al. Monascin and ankaflavin act as natural AMPK activators with PPARalpha agonist activity to down-regulate nonalcoholic steatohepatitis in high-fat diet-fed C57BL/6 mice Food Chem. Toxicol. 64 2014 94 103
30. S.M. Chan, R.Q. Sun, and X.Y. Zeng et al. Activation of PPARalpha ameliorates hepatic insulin resistance and steatosis in high fructose-fed mice despite increased endoplasmic reticulum stress Diabetes 62 2013 2095 2105
31. S. Jeong, and M. Yoon Swimming's prevention of ovariectomy-induced obesity through activation of skeletal-muscle PPARalpha Int. J. Sport Nutr. Exerc Metab. 22 2012 1 10
32. B.Q. Starley, C.J. Calcagno, and S.A. Harrison Nonalcoholic fatty liver disease and hepatocellular carcinoma: a weighty connection Hepatology 51 2010 1820 1832
33. S.L. Moak, G.C. Dougan, and C.B. MarElia et al. Enhanced glucose tolerance in pancreatic-derived factor (PANDER) knockout C57BL/6 mice Dis. Model Mech. 7 2014 1307 1315
34. M.T. Nakamura, B.E. Yudell, and J.J. Loor Regulation of energy metabolism by long-chain fatty acids Prog. Lipid Res. 53 2014 124 144
35. W.L. Chen, Y.L. Chen, and Y.M. Chiang et al. Fenofibrate lowers lipid accumulation in myotubes by modulating the PPARalpha/AMPK/FoxO1/ATGL pathway Biochem. Pharmacol. 84 2012 522 531
36. J.J. Kim, P. Li, and J. Huntley et al. FoxO1 haploinsufficiency protects against high-fat diet-induced insulin resistance with enhanced peroxisome proliferator-activated receptor gamma activation in adipose tissue Diabetes 58 2009 1275 1282